Botox may reduce chronic neuropathic pain

Botox may reduce chronic neuropathic pain

(HealthDay)—Subcutaneous botulinum toxin type A (BTX-A) injections appear to safely and effectively reduce chronic neuropathic pain in patients with spinal cord injury, according to a study published online Jan. 27 in the Annals of Neurology.

Zee-A Han, M.D., Ph.D., from the National Rehabilitation Center in Seoul, South Korea, and colleagues evaluated a one-time subcutaneous BTX-A (200 units) injection in 40 patients with spinal cord injury-associated neuropathic pain. Pain and quality of life assessments were made before treatment and at four weeks and eight weeks after the injection.

The researchers found that among the responders in the BTX-A group at four and eight weeks after injection, 55 percent and 45 percent, respectively, reported pain relief of 20 percent or greater. By comparison, only 15 percent and 10 percent of the responders in the placebo group reported a similar level of . Pain relief was tied to preservation of motor or sensory function below the neurological level of injury. For the physical health domain of the WHOQOL-BREF quality of life assessment, improvements in the BTX-A group showed a marginal trend toward significance at four weeks after the .

"These results indicate that BTX-A may reduce intractable in patients with spinal cord injury," the authors write.

Medytox, a maker of botulinum toxin products, supported the study.


Explore further

Botulinum toxin-A beneficial in painful diabetic neuropathy

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Annals of Neurology

Copyright © 2016 HealthDay. All rights reserved.

Citation: Botox may reduce chronic neuropathic pain (2016, February 9) retrieved 21 July 2019 from https://medicalxpress.com/news/2016-02-botox-chronic-neuropathic-pain.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
62 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more